Screener

Eligibility screening

LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Sponsored by Eli Lilly and CompanyStudy detailsClinicalTrials.gov

25 US sites in AZ, CA, FL, GA +10

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.